Gabriel Morris - Jun 20, 2025 Form 4 Insider Report for Immix Biopharma, Inc. (IMMX)

Role
CFO, Director
Signature
/s/ Gabriel Morris
Stock symbol
IMMX
Transactions as of
Jun 20, 2025
Transactions value $
$0
Form type
4
Date filed
6/23/2025, 04:57 PM
Previous filing
Jun 20, 2025
Next filing
Sep 17, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Morris Gabriel S CFO, Director C/O IMMIX BIOPHARMA, INC., 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES /s/ Gabriel Morris 2025-06-23 0001889967

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IMMX Common Stock 288K Jun 20, 2025 Direct
holding IMMX Common Stock 271K Jun 20, 2025 See footnote F1
holding IMMX Common Stock 24.1K Jun 20, 2025 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMMX Stock Option (Right to Buy) Award $0 +340K $0.00 340K Jun 20, 2025 Common Stock 340K $2.24 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein.
F2 Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein.
F3 The Stock Option will vest in forty-eight (48) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.